Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -118.58% is 25% above its 5-year average of -158.87%, near the high end of its 5-year range (-381.07%–-16.39%).
As of the fiscal period ended Tuesday, June 30, 2026. 58.96% below its 12-month average of -74.60%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -118.58%.
RETURN ON EQUITY (ROE)
-118.58%
RETURN ON EQUITY (ROE) AVG TTM
-74.60%
RETURN ON EQUITY (ROE) AVG 3Y
-92.89%
RETURN ON EQUITY (ROE) AVG 5Y
-158.87%
RETURN ON EQUITY (ROE) AVG 10Y
-108.29%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-58.96%
CURRENT VS 3Y AVG
-27.66%
CURRENT VS 5Y AVG
+25.36%
CURRENT VS 10Y AVG
-9.50%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-42.01%
median of 754 covered companies
CURRENT VS SECTOR MEDIAN
-182.26%
vs the sector median at left
Akebia Therapeutics, Inc.
Market Cap
$235.66M
Return on Equity (ROE)
-118.58%
TTM Avg
-74.60%
3Y Avg
-92.89%
5Y Avg
-158.87%
Market Cap
$235.97M
Return on Equity (ROE)
-1.67%
TTM Avg
19.58%
3Y Avg
23.42%
5Y Avg
29.49%
Market Cap
$235.08M
Return on Equity (ROE)
8.59%
TTM Avg
10.64%
3Y Avg
12.16%
5Y Avg
12.16%
Market Cap
$236.82M
Return on Equity (ROE)
-25.20%
TTM Avg
-25.82%
3Y Avg
5.12%
5Y Avg
5.12%
Market Cap
$237.57M
Return on Equity (ROE)
-59.27%
TTM Avg
-136.66%
3Y Avg
-113.26%
5Y Avg
-53.68%
Market Cap
$232.72M
Return on Equity (ROE)
-27.27%
TTM Avg
-92.43%
3Y Avg
-64.95%
5Y Avg
-57.80%
Market Cap
$239.01M
Return on Equity (ROE)
-31.55%
TTM Avg
-30.05%
3Y Avg
-33.97%
5Y Avg
-37.95%
Market Cap
$239.02M
Return on Equity (ROE)
-47.25%
TTM Avg
-42.23%
3Y Avg
-50.43%
5Y Avg
-29.25%
Market Cap
$231.77M
Return on Equity (ROE)
-695.56%
TTM Avg
-3698.55%
3Y Avg
-1897.26%
5Y Avg
-1268.80%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Akebia Therapeutics, Inc. (AKBA) | $235.66M | -118.58% | -74.60% | -92.89% | -158.87% |
| SIGA Technologies, Inc. (SIGA)vs › | $235.97M | -1.67% | 19.58% | 23.42% | 29.49% |
| Utah Medical Products, Inc. (UTMD)vs › | $235.08M | 8.59% | 10.64% | 12.16% | 12.16% |
| BioAge Labs Inc. (BIOA)vs › | $236.82M | -25.20% | -25.82% | 5.12% | 5.12% |
| Invivyd, Inc. (IVVD)vs › | $237.57M | -59.27% | -136.66% | -113.26% | -53.68% |
| InflaRx N.V. (IFRX)vs › | $232.72M | -27.27% | -92.43% | -64.95% | -57.80% |
| High Tide Inc. (HITI)vs › | $239.01M | -31.55% | -30.05% | -33.97% | -37.95% |
| Century Therapeutics, Inc. (IPSC)vs › | $239.02M | -47.25% | -42.23% | -50.43% | -29.25% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $231.77M | -695.56% | -3698.55% | -1897.26% | -1268.80% |
| MacroGenics, Inc. (MGNX)vs › | $231.37M | -34.04% | -95.97% | -70.55% | -68.40% |
ROE
-118.6%
ROA
-8.5%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -118.58% |
| 2026-03-31 | -74.93% |
| 2025-12-31 | -16.39% |
| 2025-09-30 | -38.24% |
| 2025-06-30 | -124.84% |
| 2025-03-31 | -184.34% |
| 2022-06-30 | -260.64% |
| 2021-12-31 | -381.07% |
| 2021-09-30 | -218.13% |
| 2021-06-30 | -171.55% |
| 2021-03-31 | -183.41% |
| 2020-12-31 | -154.86% |
| 2020-09-30 | -122.95% |
| 2020-06-30 | -104.13% |
| 2020-03-31 | -67.61% |
| 2019-12-31 | -70.84% |
| 2019-09-30 | -58.50% |
| 2019-06-30 | -47.18% |
| 2019-03-31 | -39.00% |
| 2018-12-31 | -27.03% |
| 2018-09-30 | -49.99% |
| 2018-06-30 | -41.19% |
| 2018-03-31 | -28.31% |
| 2017-12-31 | -64.46% |
| 2017-09-30 | -127.22% |
| 2017-06-30 | -246.03% |
| 2017-03-31 | -504.60% |
| 2016-12-31 | -199.28% |
| 2016-09-30 | -116.91% |
| 2016-06-30 | -75.71% |
| 2016-03-31 | -45.19% |
| 2015-12-31 | -46.35% |
| 2015-09-30 | -35.23% |
| 2015-06-30 | -27.45% |
| 2015-03-31 | -40.20% |
| 2014-12-31 | -35.58% |
| 2014-09-30 | -28.70% |
| 2014-06-30 | -22.24% |
| 2014-03-31 | -17.40% |
| 2013-12-31 | -42.81% |
| 2013-09-30 | -29.45% |
